Advanced Enzyme Technologies’ board has approved the approval to acquire additional stake of 15% of Equity Share capital of JC Biotech (70% subsidiary of the Company) (JCB) by way of purchase of 31,06,680 Equity Shares from the existing shareholder(s) of JCB for a consideration of Rs 211.25 Million i.e. Rs. 68 per Equity Share, and authorized the signing of amendment to the Shareholders' Agreement in this regard. On completion of the said investment, the shareholding of the company in JCB will increase from 70% to 85%.
Advanced Enzyme Technologies is a research driven company with global leadership in manufacturing of enzymes and probiotics. It is the largest Indian enzyme company engaged in the research and development, manufacturing and marketing of vast proprietary products developed from many indigenous enzymes & probiotics.
